OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin
Ligong Chen(Diagnostics for the Real World (United States)), Kathleen M. Giacomini(University of California, San Francisco), Jason Liu(American Heart Association), Sook Wah Yee(Pfizer (United States)), Kayvan R. Keshari(Memorial Sloan Kettering Cancer Center), Eugene C. Chen(University of California, San Francisco), Kari M. Morrissey(University of California, San Francisco), John Kurhanewicz(University of California, San Francisco), Shuanglian Li(University of California, San Francisco), Michael J. Lin(University of California, San Francisco), Yan Shu(Temple College), Kevan M. Shokat(Howard Hughes Medical Institute), Kaveh Ashrafi(University of California, San Francisco), Huan‐Chieh Chien(National Yang Ming Chiao Tung University), Xiaomin Liang(University of California, San Francisco), Youcai Zhang(Tianjin University of Science and Technology), Arik A. Zur(University of California, San Francisco), J.M. Ostrem(Broad Institute), Lu Xu(University of California, San Francisco), Noah Younger(University of California, San Francisco)
Cited by 237
Related Papers
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
|Nature|2013|2.5k
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
|Nature|2010|1.8k
IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response
|Science|2007|1.4k